Encompass Health Corporation
EHC
$112.67
$0.670.60%
NYSE
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 16.91% | 24.54% | 34.67% | 38.01% | 26.85% |
| Total Depreciation and Amortization | 5.10% | 9.60% | 12.66% | 11.27% | 16.49% |
| Total Amortization of Deferred Charges | -- | -- | -- | 2.11% | -- |
| Total Other Non-Cash Items | 23.41% | 23.46% | 13.54% | 58.96% | 7.98% |
| Change in Net Operating Assets | -94.46% | 66.95% | -368.75% | 132.56% | 85.71% |
| Cash from Operations | 1.12% | 24.29% | 20.85% | 38.71% | 24.44% |
| Capital Expenditure | -26.85% | 0.00% | -17.00% | 6.14% | 1.47% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -1.43% | -466.67% | -52.58% | -238.89% | -12.00% |
| Cash from Investing | -24.64% | -4.42% | -22.21% | 2.11% | 0.43% |
| Total Debt Issued | 433.33% | -- | 20.00% | -- | -- |
| Total Debt Repaid | 30.61% | -70.23% | -60.00% | -1,824.59% | -479.63% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -266.18% | -47.62% | -328.93% | -7,400.00% | -1,600.00% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -13.33% | -14.77% | -13.21% | -14.09% | 0.00% |
| Other Financing Activities | -157.86% | -441.67% | -221.43% | -343.18% | 415.38% |
| Cash from Financing | -26.48% | -81.85% | -221.18% | -404.68% | -36.02% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -360.12% | 55.32% | -100.44% | -104.86% | 231.25% |